Terms: = Ovarian cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Diagnosis
388 results:
1. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
[TBL] [Abstract] [Full Text] [Related]
2. ovarian cancer is detectable from peripheral blood using machine learning over T-cell receptor repertoires.
Zuckerbrot-Schuldenfrei M; Aviel-Ronen S; Zilberberg A; Efroni S
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38483254
[TBL] [Abstract] [Full Text] [Related]
3. Deciphering the potential of proteomic-based biomarkers in women's reproductive diseases: empowering precision medicine in gynecology.
Kaur Jawanda I; Soni T; Kumari S; Prabha V
Biomarkers; 2024 Feb; 29(1):7-17. PubMed ID: 38252065
[TBL] [Abstract] [Full Text] [Related]
4. Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperatively.
Xu T; Nie X; Zhang L; Meng H; Jiang Y; Wan Y; Cheng W
J Cancer Res Clin Oncol; 2024 Jan; 150(1):19. PubMed ID: 38243112
[TBL] [Abstract] [Full Text] [Related]
5. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.
Cai G; Huang F; Gao Y; Li X; Chi J; Xie J; Zhou L; Feng Y; Huang H; Deng T; Zhou Y; Zhang C; Luo X; Xie X; Gao Q; Zhen X; Liu J
Lancet Digit Health; 2024 Mar; 6(3):e176-e186. PubMed ID: 38212232
[TBL] [Abstract] [Full Text] [Related]
6. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
[TBL] [Abstract] [Full Text] [Related]
7. Construction of monocyte-related prognosis model based on comprehensive analysis of bulk RNA-seq and single-cell RNA-seq in high-grade serous ovarian cancer.
Xu Y; Tan S; Huang W; Wang YX
Medicine (Baltimore); 2023 Dec; 102(50):e36548. PubMed ID: 38115318
[TBL] [Abstract] [Full Text] [Related]
8. Aneuploidy Landscape in Precursors of ovarian cancer.
Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
[TBL] [Abstract] [Full Text] [Related]
9. Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial.
Herzog C; Jones A; Evans I; Reisel D; Olaitan A; Doufekas K; MacDonald N; Rådestad AF; Gemzell-Danielsson K; Zikan M; Cibula D; Dostálek L; Paprotka T; Leimbach A; Schmitt M; Ryan A; Gentry-Maharaj A; Apostolidou S; Rosenthal AN; Menon U; Widschwendter M
Int J Cancer; 2024 Feb; 154(4):679-691. PubMed ID: 37861205
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
11. The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [
Sadeghi MH; Sina S; Alavi M; Giammarile F
Ann Nucl Med; 2023 Dec; 37(12):645-654. PubMed ID: 37768493
[TBL] [Abstract] [Full Text] [Related]
12. Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
Sobocan M; Chandrasekaran D; Sideris M; Blyuss O; Fierheller C; Kalra A; Sia J; Miller RE; Mills-Baldock T; Crusz SM; Sun L; Evans O; Robbani S; Jenkins LA; Ahmed M; Kumar A; Quigley M; Lockley M; Faruqi A; Casey L; Brockbank E; Phadnis S; Trevisan G; Singh N; Legood R; Manchanda R
BJOG; 2024 May; 131(6):848-857. PubMed ID: 37752678
[TBL] [Abstract] [Full Text] [Related]
13. Necroptosis-related regulatory pattern and scoring system for predicting therapeutic efficacy and prognosis in ovarian cancer.
Lai H; Guo Y; Wu L; Yusufu A; Zhong Q; Liao Z; Ma J; Shi W; Yang G; Chen S
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1893. PubMed ID: 37681751
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Significance of the TK1-Specific Activity in the Early Detection of ovarian cancer.
Osredkar J; Jagarlamudi KK; Cviič D; Škof E; Cvjetićanin B; Zore A; Lukanović D; Eriksson S; Meglič L
Oncology; 2024; 102(1):17-29. PubMed ID: 37673047
[TBL] [Abstract] [Full Text] [Related]
15. Seeing beyond the tumor: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer.
Ren J; Mao L; Zhao J; Li XL; Wang C; Liu XY; Jin ZY; He YL; Li Y; Xue HD
Radiol Med; 2023 Aug; 128(8):900-911. PubMed ID: 37368228
[TBL] [Abstract] [Full Text] [Related]
16. Identification and validation of shared genes and key pathways in endometriosis and endometriosis-associated ovarian cancer by weighted gene co-expression network analysis and machine learning algorithms.
Du Y; Hu Y; Zhang F; Guan Y; Sheng Y
J Obstet Gynaecol Res; 2023 Aug; 49(8):2135-2150. PubMed ID: 37340502
[TBL] [Abstract] [Full Text] [Related]
17. Profiling the metabolome of uterine fluid for early detection of ovarian cancer.
Wang P; Ma J; Li W; Wang Q; Xiao Y; Jiang Y; Gu X; Wu Y; Dong S; Guo H; Li M
Cell Rep Med; 2023 Jun; 4(6):101061. PubMed ID: 37267943
[TBL] [Abstract] [Full Text] [Related]
18. diagnosis of ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays.
Krumm N; Khasnavis NS; Radke M; Banda K; Davies HR; Pennil C; McLean K; Paulson VA; Konnick EQ; Johnson WC; Huff G; Nik-Zainal S; Swisher EM; Lockwood CM; Salipante SJ
JCO Precis Oncol; 2023 May; 7():e2200720. PubMed ID: 37196218
[TBL] [Abstract] [Full Text] [Related]
19. Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas.
Torkildsen CF; Thomsen LCV; Sande RK; Krakstad C; Stefansson I; Lamark EK; Knappskog S; Bjørge L
Cancer Med; 2023 Jul; 12(13):14183-14195. PubMed ID: 37191035
[TBL] [Abstract] [Full Text] [Related]
20. Malignant Germ Cell Tumors of the Ovary: Clinical and Imaging Features.
Rogers D; Menias C; Shaaban A
Radiol Clin North Am; 2023 Jul; 61(4):579-594. PubMed ID: 37169425
[TBL] [Abstract] [Full Text] [Related]
[Next]
